Search For "dr balram bhargava"
ICMR issues guidelines for management of Type 1 Diabetes
Updated : 9 months, 3 weeks ago IST
New Delhi [India], June 6 (ANI): Indian Council for Medical Research (ICMR) on Monday issued guidelines for the management of type 1 Diabetes. The guidelines are released by Prof. (Dr) Balram Bhargava, Secretary-DHR and DG-ICMR.
Read More
ICMR launches 'IBD NutriCare' app on World Inflammatory Bowel Disease Day
Updated : 10 months, 2 weeks ago IST
New Delhi [India], May 19 (ANI): Indian Council of Medical Research, launched "IBD NutriCare App" for Inflammatory Bowel Disease (IBD) patients on the occassion of World Inflammatory Bowel Disease Day on Thursday.
Read More
ICMR DG questions WHO's COVID death estimates for India
Updated : 10 months, 4 weeks ago IST
New Delhi [India], May 5 (ANI): After World Health Organization's (WHO) excess mortality estimates for COVID, the Director General of the Indian Council of Medical Research (ICMR) Dr Balram Bhargava on Thursday said the country has systemic data pool and it does not need to rely on "modellin
Read More
ICMR DG Dr Balram Bhargava's tenure extended by three months: Sources
Updated : 11 months, 3 weeks ago IST
New Delhi [India], April 12 (ANI): The term of Indian Council of Medical Research (ICMR) Director-General Dr Balram Bhargava has been extended by three months until further orders, said sources.
Read More
92 pc of COVID deaths in 2022 so far were among unvaccinated individuals:
Updated : 1 year ago IST
New Delhi [India], March 3 (ANI): Stating that COVID-19 vaccine effectiveness in mortality prevention has been measured, the Union Health Ministry informed on Thursday that one dose is 98.9 per cent effective and if both doses are administered then its efficacy increases to 99.3 per cent.
Read More
India heading towards becoming vaccine super-power: DG ICMR
Updated : 1 year, 1 month ago IST
New Delhi [India], February 10 (ANI): Director General of Indian Council of Medical Research (ICMR) Dr Balram Bhargava on Thursday hailed the 96 per cent nationwide COVID-19 vaccination coverage of the first dose and said that India is heading towards becoming a vaccine super-power.
Read More
Deaths have been considerably reduced due to COVID-19 vaccination: ICMR
Updated : 1 year, 2 months ago IST
New Delhi [India], January 20 (ANI): Indian Council of Medical Research (ICMR) head Dr Balram Bhargava, in a health briefing, on Thursday asserted that deaths have been considerably reduced due to COVID-19 vaccinations in this third surge of the coronavirus infection.
Read More
India was able to provide COVID-19 vaccines to over 100 countries with phi
Updated : 1 year, 2 months ago IST
New Delhi [India], January 16 (ANI): As India marks one year of the COVID-19 vaccination drive on Sunday, Dr Balram Bhargava, DG ICMR said that the country was able to provide vaccines to over 100 countries in line with our philosophy of 'Vasudhaiva Kutumbakam'.
Read More
COVID-19: Oral anti-viral drug Molnupiravir is not included in national ta
Updated : 1 year, 2 months ago IST
New Delhi [India], January 5 (ANI): Indian Council of Medical Research (ICMR) head Dr. Balram Bhargava on Wednesday stated that the oral anti-viral drug Molnupiravir capsules are not included in the national task force treatment for COVID-19 as it has side effects.
Read More
DCGI approves India-made RT-PCR kit to detect Omicron: Centre
Updated : 1 year, 2 months ago IST
New Delhi [India], January 5 (ANI): An RT-PCR test kit for detecting new coronavirus variant Omicron has been developed in India in partnership with Tata MD and the Indian Council of Medical Research (ICMR), said Dr Balram Bhargava, Director General of ICMR on Wednesday.
Read More
Omicron is predominant circulating strain in India: Centre
Updated : 1 year, 2 months ago IST
New Delhi [India], January 5 (ANI): The new coronavirus variant, Omicron, is the predominant circulating strain in India, Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava said on Wednesday.
Read More
Durability of immunity post-COVID-19 infection persists for 9 months: DG I
Updated : 1 year, 3 months ago IST
New Delhi [India], December 30 (ANI): The durability of immunity after the COVID-19 infection persists for at least 9 months as per the evidence-based studies from different countries globally, said Dr. Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) on Thursd
Read More
